Where Do You Draw Blood From a Patient With a Mastectomy?

For decades, the standard rule has been to draw blood from the arm on the opposite side of the mastectomy. The concern behind this practice is lymphedema, a chronic swelling condition that can develop when lymph nodes are removed or damaged during breast cancer surgery. But emerging research is complicating that blanket rule, with several professional societies now recommending individualized risk assessments instead of automatic avoidance of the affected side. Understanding the full picture matters whether you are a patient about to have labs drawn or a caregiver trying to follow best practices.

Why the Opposite Arm Became the Default

When a mastectomy involves removal of axillary lymph nodes (the nodes under the arm), the lymphatic drainage system on that side of the body is disrupted. Lymph fluid, which normally filters through those nodes on its way back into the bloodstream, can back up in the arm and hand, causing swelling, tightness, and discomfort. This condition, breast cancer-related lymphedema, can become permanent and difficult to manage once it develops.

Out of concern that puncturing a vein on the affected side could introduce bacteria or cause local trauma that tips a compromised lymphatic system into lymphedema, hospitals adopted a near-universal policy: no blood draws, no IV lines, no blood pressure cuffs on the arm next to the mastectomy site. The traditional protocol directs all vascular access to the contralateral arm, meaning the one on the opposite side of the body from the surgery.¹ This precaution became so deeply embedded in nursing education and hospital policy that many clinicians treat it as an absolute rule.

What the Research Actually Shows

The evidence supporting the blanket ban is thinner than most people realize. A comprehensive review of the literature identified 31 original research articles examining whether activities like blood draws, blood pressure measurements, skin puncture, air travel, and extreme temperatures on the affected side increase the risk of lymphedema. Among the studies that supported precautionary guidelines, most offered low-level or inconclusive evidence. Only four higher-quality studies showed a significant association, and those primarily linked lymphedema to skin infections rather than routine venipuncture.²

The most robust data comes from a prospective study of over 3,000 arm volume measurements in breast cancer patients. Researchers found no significant association between undergoing blood draws or injections on the ipsilateral (same-side) arm and increases in arm volume. The same study found no meaningful connection between air travel and lymphedema risk either.³ What did significantly predict arm swelling were factors like having a BMI of 25 or higher, undergoing full axillary lymph node dissection, receiving radiation to the regional lymph nodes, and developing cellulitis, a bacterial skin infection.³

In other words, the actual risk factors are things tied to the extent of surgery, radiation treatment, body composition, and infection, not the act of drawing blood from a vein on the same side.

Professional Societies Are Changing Their Stance

This evidence gap has not gone unnoticed. Several major medical organizations, including the Society for Ambulatory Anesthesia, the American Society of Breast Surgeons, and the Australian and New Zealand College of Anaesthetists, now support risk-based, individualized assessments rather than a blanket prohibition on using the arm on the mastectomy side.⁴ The shift reflects a growing recognition that forcing all vascular access to one arm, or to the feet and legs, can create its own set of problems.

One evidence-based practice change project put this new thinking into action. After implementing a protocol allowing use of the ipsilateral arm for blood draws, more than 100 breast cancer patients were tracked over 12 months. None of them developed lymphedema as a result. The shift also eliminated the need for foot sticks and calf blood pressure measurements, procedures that many patients find uncomfortable and that carry their own complications.¹

When Extra Caution Still Makes Sense

None of this means that every mastectomy patient should casually offer the ipsilateral arm. The risk of lymphedema is not evenly distributed across all surgical scenarios, and certain patients remain at genuinely higher risk.

The type of lymph node surgery matters a great deal. A full axillary lymph node dissection, where the surgeon removes many nodes from the armpit, disrupts far more of the lymphatic network than a sentinel lymph node biopsy, which targets just one or a few nodes for testing. Complications including arm swelling occur with both procedures but are less frequent after sentinel node biopsy alone.⁵ A patient who has had a full axillary dissection plus radiation to the lymph node region is in a very different risk category from someone who had a sentinel biopsy with no radiation.

Other factors that raise the stakes include:

Prior cellulitis: A history of skin infection on the affected arm is one of the most clearly established risk factors for lymphedema, and a venipuncture that introduces bacteria in this context could compound the problem.
Existing swelling: If a patient already shows signs of lymphedema, even mild, extra precaution around that arm is warranted.
Obesity: A BMI at or above 25 independently raises lymphedema risk, so the margin for error shrinks.
Regional radiation: Radiation to the axillary or supraclavicular lymph nodes compounds the surgical damage to the lymphatic system.

For patients who stack several of these risk factors, the traditional avoidance of the ipsilateral arm remains a reasonable precaution even as the broader evidence shifts. The emerging consensus is not that the rule was wrong for everyone, but that it was too broad for everyone.

The Bilateral Mastectomy Problem

The traditional rule becomes especially difficult for patients who have had mastectomies on both sides. If both arms are off limits, clinicians face an awkward situation: where, exactly, do you draw blood? Historically, the workaround has been to use veins in the hands, the feet, or the lower legs. Some hospitals have ordered blood pressure cuffs placed on the calf instead of the upper arm. These alternatives are workable but far from ideal. Foot veins are harder to access, leg sticks carry a higher risk of blood clots in some patients, and the experience is generally more uncomfortable.

The newer evidence has particular relevance here. If ipsilateral blood draws do not meaningfully increase lymphedema risk for the majority of patients, then forcing bilateral mastectomy patients into awkward alternative sites may cause more harm than it prevents. The practice change project that tracked outcomes after switching to ipsilateral arm use found that it specifically eliminated the need for foot sticks and calf blood pressures, a benefit that disproportionately helps bilateral patients.¹

In practice, many clinicians now choose the arm on the side that had the less invasive nodal procedure, or the side without radiation, when one arm must be used. The key is to make the decision based on the individual patient’s surgical history and lymphedema risk profile rather than defaulting to a foot stick.

Central Venous Access Devices as an Alternative

For patients undergoing long-term chemotherapy, the question of where to draw blood often becomes moot because a central venous access device is placed. Two common options are a peripherally inserted central catheter (PICC line) and a totally implanted port.⁶ Both types sit with their tip in a large central vein near the heart, and both can be used to draw blood as well as deliver medication.

A port is implanted under the skin, usually in the upper chest, and accessed by a special needle through the skin when needed. A PICC line enters through a peripheral vein in the upper arm and threads to the central venous system. Both bypass the question of which arm vein to use entirely. For patients who will need frequent blood draws over months of treatment, a central line spares them repeated venipunctures and sidesteps the ipsilateral arm debate altogether.

That said, central lines come with their own risks, including bloodstream infections, blood clots, and mechanical complications. They are a good fit for patients already receiving IV chemotherapy but would be excessive for someone who only needs routine labs once or twice a year at follow-up appointments. For those patients, the question of which peripheral vein to use remains relevant.

What to Do as a Patient

If you have had a mastectomy, you may have been told never to allow blood draws, IVs, or blood pressure readings on your affected arm. That advice was given in good faith and is still followed at many hospitals. But if you find yourself in a situation where the opposite arm is genuinely difficult to access, or if you have had bilateral surgery and are being asked to endure painful foot sticks, it is worth having a conversation with your oncology team about whether the blanket restriction is necessary for your specific case.

A few things are worth knowing going into that conversation. First, the extent of your nodal surgery matters far more than the simple fact of having had a mastectomy. If you had only a sentinel node biopsy and no axillary radiation, your lymphedema risk is substantially lower than someone who had a full dissection. Second, your overall health profile factors in: weight, history of infection on that arm, whether you have ever had any swelling. Third, if your team does approve use of the ipsilateral arm, that does not mean the precaution was pointless. It means the precaution has been evaluated against your personal risk and found to be unnecessary in your situation.

Many patients wear medical alert bracelets or wristbands indicating “no blood draws” on a particular arm. If your clinical team has updated your restrictions, make sure that information is reflected in your medical record and on any wearable alerts, so that a future nurse or phlebotomist in an unrelated setting knows the current protocol.

Why Cellulitis Matters More Than the Needle

One of the more striking takeaways from the research is that cellulitis, a bacterial infection of the skin and underlying tissue, emerged as a clear and well-established risk factor for lymphedema in multiple analyses. The large prospective study that cleared blood draws and injections of blame found that cellulitis was highly significant as a predictor of arm volume increase.³ The Lancet review reached a similar conclusion, identifying skin infections and prior inflammation on the ipsilateral arm as among the most clearly established risk factors.²

This is relevant because a clean, well-performed venipuncture is very different from a skin infection. The fear driving the old policy was essentially that a needle stick could introduce bacteria or cause trauma that leads to infection, which then triggers lymphedema. But the evidence suggests it is the infection itself, not the puncture, that drives the risk. A sterile blood draw performed by a skilled phlebotomist is a far cry from a case of cellulitis.

For patients, the practical implication is that caring for your skin on the affected side, treating cuts and scrapes promptly, watching for redness or warmth that could signal infection, and managing conditions like eczema that break down the skin barrier, likely matters more than refusing every blood draw. Preventing infection is a higher-value activity than avoiding venipuncture.

How Hospital Policies Lag Behind the Evidence

If you have read this far and are wondering why your hospital still insists on using the opposite arm, you are not alone. Clinical tradition changes slowly, especially when the traditional practice seems harmless on its surface. Avoiding one arm for blood draws feels like a costless precaution, so many institutions have not felt urgency to update their policies even as the evidence base has shifted.

Researchers in Japan recently described this gap between evidence and practice, noting that the shift from blanket prohibition to personalized assessment aligns clinical practice with modern evidence, promotes patient autonomy, and prevents the continuation of outdated norms.⁴ The fact that multiple countries and multiple professional societies are independently arriving at the same conclusion suggests the field is approaching a tipping point, though translation into everyday hospital practice will take time.

In the meantime, patients may encounter different rules at different facilities, and even different nurses within the same hospital may follow different protocols depending on when they were trained. This inconsistency can be frustrating, but it reflects a genuine transition period in clinical thinking rather than anyone being careless. If you encounter a strict “never use that arm” policy and your personal risk profile suggests flexibility is appropriate, ask your oncologist to document specific guidance in your chart. A note from your cancer specialist carries weight with the phlebotomist or emergency nurse who is meeting you for the first time.